Destination Therapy: Does Progress Depend on Left Ventricular Assist Device Development?

Heart Failure Clinics

Volumn 3, Issue 3, 2007, Pages 349-367

  von Bayern, Manuel Prinz ^a   Cadeiras, Martin ^a   Deng, Mario C ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ASSISTED CIRCULATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEATH; FOOD AND DRUG ADMINISTRATION; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; INFECTION; MORBIDITY; PROSTHESIS FAILURE; QUALITY OF LIFE; REVIEW; SURVIVAL; UNITED STATES;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548172496     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.04.007     Document Type: Review

References (115)

1. Bardy G.H., Lee K.L., Mark D.B., et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
2. Cleland J.G., Daubert J.C., Erdmann E., et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
3. Crespo Leiro M.G., and Paniagua Martin M.J. Management of advanced or refractory heart failure. Rev Esp Cardiol 57 (2004) 869-883
4. Jimenez J., Bennett Edwards L., et al. Should stable UNOS status 2 patients be transplanted?. J Heart Lung Transplant 24 (2005) 178-183
5. Juurlink D.N., Mamdani M.M., Lee D.S., et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351 (2004) 543-551
6. McMurray J.J., and Pfeffer M.A. Heart failure. Lancet 365 (2005) 1877-1889
7. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
8. Portner P.M. The state of destination therapy for the treatment of congestive heart failure. Curr Opin Organ transplant 11 (2006) 546-552
9. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
10. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129 (2005) 9-17
11. Stevenson L.W. Left ventricular assist devices as destination therapy for end-stage heart failure. Curr Treat Options Cardiovasc Med 6 (2004) 471-479
12. Parides M.K., Moskowitz A.J., Ascheim D.D., et al. Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Ann Thorac Surg 82 3 (2006) 1140-1146
13. Chen E., Sapirstein W., Ahn C., et al. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg 82 3 (2006) 773-775
14. Available at: http://www.intermacs.org. Accessed February 22, 2007.
15. Goldstein D.J., Zucker M., Arroyo L., et al. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J Am Coll Cardiol 45 6 (2005) 962-963
16. Siegenthaler M.P., Westaby S., Frazier O.H., et al. Advanced heart failure: study feasibility of long term continuous axial flow pump support. Eur Heart J 26 (2005) 1031-1038
17. Westaby S., Banning A.P., Saito S., et al. Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation 105 (2002) 2588-2591
18. Esmore D.S., Kaye D., Salamonsen R., et al. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure. J Heart Lung Transplant 24 (2005) 1150-1154
19. Young J.B., Rogers J.G., Portner P.E., et al. Bridge to eligibility: LVAS-support in patients with relative contraindications to transplantation. J Heart Lung Transplant 24 (2005) S75
20. Jurmann M.J., Weng Y., Drews T., et al. Permanent mechanical circulatory support in patients of advanced age. Eur J Cardiothorac Surg 25 (2004) 610-618
21. Deng M.C., Edwards L.B., Taylor D.O., et al. Mechanical circulatory support device database of the international society for heart and lung transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
22. Deng M.C., Erren M., Tjan T.D., et al. Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression. Thorac Cardiovasc Surg 47 Suppl 2 (1999) 326-331
23. Holman W.L., Park S.J., Long J.W., et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 23 (2004) 1359-1365
24. Horton S.C., Khodaverdian R., Chatelain P., et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol 45 (2005) 1435-1440
25. Horton S.C., Khodaverdian R., Powers A., et al. Left ventricular assist device malfunction: a systematic approach to diagnosis. J Am Coll Cardiol 43 (2005) 1574-1583
26. Houel R., Mazoyer E., Boval B., et al. Platelet activation and aggregation profile in prolonged external ventricular support. J Thorac Cardiovasc Surg 128 (2004) 197-202
27. Available at: http://www.jcaho.org. Accessed July 15, 2005.
28. Simon D., Fischer S., Grossman A., et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 40 (2005) 1108-1115
29. Choi L., Choudhri A.F., Pillarisetty V.G., et al. Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections. J Heart Lung Transplant 18 11 (1999) 1103-1110
30. Bruschi G., Ribera E., Lanfranconi M., et al. Bridge to transplantation with the MicroMed DeBakey ventricular assist device axial pump: a single centre report. J Cardiovasc Med (Hagerstown) 7 2 (2006) 114-118
31. Goldstein D.J. Worldwide experience with MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 108 Suppl 1 (2003) 272-277
32. Mehta S.M., Pae Jr. W.E., Rosenberg G., et al. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg 71 3 Suppl (2001) S156-S161 [discussion: S183-4]
33. El-Banayosy A., Arusoglu L., Kizner L., et al. Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 75 (2003) 1469-1475
34. Pae W.E., Connell J.M., Boehmer J.P., et al. CUBS Study Group. Neurologic events with a totally implantable left ventricular assist device: European Lionheart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant 26 (2007) 1-8
35. Mehta S.M., Silber D., Boehmer J.P., et al. Report of the first U.S. patient successfully supported long term with the LionHeart completely implantable left ventricular assist device system. ASAIO J 52 6 (2006) e31-e32
36. Asai T., Baron H.M., von Bayern M.P., et al. A mouse aortic patch model for mechanical circulatory support. J Heart Lung Transplant 24 8 (2005) 1129-1132
37. Arrecubieta C., Asai T., Bayern M., et al. The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis 193 8 (2006) 1109-1119
38. Sun B.C., Catanese K.A., Spanier T.B., et al. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 68 2 (1999) 688-694
39. Yuh D.D., Albaugh M., Ullrich S., et al. Treatment of ventricular assist device driveline infection with vacuum-assisted closure system. Ann Thorac Surg 80 4 (2005) 1493-1495
40. Baradarian S., Stahovich M., Krause S., et al. Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J 52 3 (2006) 354-356
41. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 26 (2006) 2725-2732
42. Lazar R.M., Shapiro P.A., Jaski B.E., et al. Neurological events during long-term mechanical circulatory support for heart failure: the randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) experience. Circulation 109 (2004) 2423-2427
43. Kalya A.V., Tector A.J., Crouch J.D., et al. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution. J Heart Lung Transplant 24 (2005) 1973-1975
44. Guthikonda S., Lev E.I., and Kleiman N.S. Resistance to antiplatelet therapy. Curr Cardiol Rep 7 (2005) 242-248
45. Rieder M.J., Reiner A.P., Gage B.F., et al. Effect of VKORC1 Haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352 (2005) 2285-2293
46. Flynn J.D., Camp Jr. P.C., Jahania M.S., et al. Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII. ASAIO J 50 5 (2004) 519-521
47. Frazier O.H., Dowling R.D., Gray Jr. L.A., et al. The total artificial heart: where we stand. Cardiology 101 (2004) 117-21
48. Kogan A., Berman M., Kassif Y., et al. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation. J Heart Lung Transplant 24 3 (2005) 347-349
49. Potapov E.V., Pasic M., Bauer M., et al. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg 74 6 (2002) 2182-2183
50. Tual L., Kirsch M., Servant J.M., et al. rFVIIa administration in patient with a left ventricular assistance patient. Ann Fr Anesth Reanim 25 1 (2006) 29-32
51. Martin J., Siegenthaler M.P., Friesewinkel O., et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 25 (2004) 971-977
52. Salzberg S.P., Lachat M.L., von Harbou K., et al. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 27 (2005) 222-225
53. Dang N.C., Topkara V.K., Mercando M., et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 25 1 (2006) 1-6
54. Oz M.C., Goldstein D.J., Pepino P., et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 92 9 Suppl (1995) II169-II173
55. Rao V., Oz M.C., Flannery M.A., et al. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 125 (2003) 855-862
56. Santambrogio L., Bianchi T., Fuardo M., et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interactive Cardiovascular and Thoracic Surgery 5 (2006) 379-382
57. Field M.E., Solomon S.D., Lewis E.F., et al. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. J Card Fail 12 8 (2006) 616-620
58. Fukamachi K., Horvath D.J., Massiello A.L., et al. Development of a small implantable right ventricular assist device. ASAIO J 51 6 (2005) 730-735
59. Christiansen S., Perez-Bouza A., Reul H., et al. In vivo experimental testing of a microaxial blood pump for right ventricular support. Artif Organs 30 2 (2006) 94-100
60. Klodell Jr. C.T., Morey T.E., Lobato E.B., et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg 83 1 (2007) 68-71
61. Dowling R.D., Park S.J., Pagani F.D., et al. HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 25 (2004) 958-963
62. Dowling R.D., Gray Jr. L.A., Etoch S.W., et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 127 1 (2004) 131-141
63. Birks E.J., Tansley P.D., Yacoub M.H., et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 23 (2004) 964-969
64. Pagani F.D., Long J.W., Dembitsky W.P., et al. Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Ann Thorac Surg 82 4 (2006) 1413-1418
65. Martin J., Friesewinkel O., Benk C., et al. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. J Heart Lung Transplant 25 4 (2006) 384-390
66. Mussivand T., Hetzer R., Vitali E., et al. Clinical results with an ePTFE inflow conduit for mechanical circulatory support. J Heart Lung Transplant 23 12 (2004) 1366-1370
67. Westaby S., Frazier O.H., and Banning A. Six years of continuous mechanical circulatory support. N Engl J Med 355 (2006) 325-327
68. Slaughter M. Destination therapy: the future is arriving. Congest Heart Fail 11 (2005) 155-156
69. Lietz K., Long J., Kfoury A.G., et al. The impct of patient selection on long-term outcomes of left-ventricular assist device implantation as destination therapy for endstage heart failure (abstr). J Heart Lung Transplant 25 2 Suppl (2006) S131
70. Faggian G., Santini F., Franchi G., et al. Insights from continued use of a Novacor Left Ventricular Assist System for a period of 6 years. J Heart Lung Transplant 24 (2005) 1444
71. Feller E.D., Sorensen E.N., Haddad M., et al. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg 83 3 (2007) 1082-1088
72. Deng M.C., and Naka Y. Mechanical circulatory support therapy in advanced heart failure (2007), Imperial College Press, London
73. Frazier O.H., and Kirklin J.K. Mechanical circulatory support. ISHLT Monograph Series Volume 1 (2006), Elsevier, Philadelphia
74. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Clin Infect Dis 38 8 (2004) 1128-1130
75. Schmid C., Tjan T.D., Etz C., et al. First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant 24 (2005) 1188-1194
76. Vitali E., Lanfranconi M., Ribera E., et al. Successful experience in bridging patients to heart transplantation with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 75 4 (2003) 1200-1204
77. Gordon R.J., Quagliarello B., and Lowy F.D. Ventricular assist device-related infections. Lancet Infect Dis 6 7 (2006) 426-437
78. Klotz S., Stypmann J., Welp H., et al. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?. Ann Thorac Surg 82 (2006) 1774-1778
79. Fynn-Thompson F., and Almond C. Pediatric Ventricular Assist Devices. Pediatr Cardiol 28 (2007) 149-155
80. Minami K., El-Banayosy A., Sezai A., et al. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. Artif Organs 24 (2000) 421-426
81. Schmid C., Debus V., Gogarten W., et al. Pediatric assist with the Medos and Excor systems in small children. ASAIO J 52 5 (2006) 505-508
82. Baldwin J.T., Borovetz H.S., Duncan B.W., et al. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation 113 (2006) 147-155
83. Klotz S., Deng M.C., Wilhelm M.J., et al. Left ventricular pressure and volume unloading during pulsatile versus non-pulsatile LVAD-support. Ann Thorac Surg 77 (2004) 143-149
84. Thohan V., Stetson S.J., Nagueh S.F., et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant 24 5 (2005) 566-575
85. Ündar A. Myths and truths of pulsatile and nonpulsatile perfusion during acute and chronic cardiac support. Artif Organs 28 5 (2004) 439-443
86. Bourque K., Dague C., Farrar D., et al. In vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta. Artif Organs 30 8 (2006) 638-642
87. Myers T.J., Palanichamy N., La Francesca S., et al. Management of multiple left ventricular assist device failures in a patient. J Heart Lung Transplant 26 1 (2007) 98-100
88. Ankersmit H.J., Tugulea S., Spanier T., et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354 9178 (1999) 550-555
89. Miller L.W., Nelson K.E., Bostic R.R., et al. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant 25 (2006) 778-784
90. Clegg A.J., Scott D.A., Loveman E., et al. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess 9 45 (2005) 1-148
91. Digiorgi P.L., Reel M.S., Thornton B., et al. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 24 (2005) 200-204
92. Sharples L.D., Dyer M., Cafferty F., et al. Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Heart Lung Transplant 25 11 (2006) 1336-1343
93. Smetana G.W., Lawrence V.A., Cornell J.E., et al. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 144 (2006) 581-595
94. Stevenson L.W., Miller L.W., Desvigne-Nickens P., et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 110 (2004) 975-981
95. DeRose Jr. J.J., Umana J.P., Argenziano M., et al. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 30 7 (1997) 1773-1777
96. McCarthy P.M., Smedira N.O., Vargo R.L., et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 115 4 (1998) 904-912
97. Schmid C., Hammel D., Deng M.C., et al. Ambulatory care of patients with left ventricular assist devices. Circulation 100 Suppl II (1999) II-224-II-228
98. Weitkemper H.H., El-Banayosy A., Arusoglu L., et al. Mechanical circulatory support: reality and dreams experience of a single center. J Extra Corpor Technol 36 (2004) 169-173
99. El-Banayosy A., Arusoglu L., Kizner L., et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 119 (2000) 581-587
100. Asai T., Lee M.H., Arrecubieta C., et al. Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus. J Thorac Cardiovasc Surg 113 (2007) 1147-1153
101. Hammel D., Tjan D.T., Scheld H.H., et al. Successful treatment of a Novacor LVAD malfunction without repeat sternotomy. Thorac Cardiovasc Surg 46 (1998) 154-156
102. Simsir S.A., Lin S.S., Ellis M.F., et al. HeartMate XVE malfunction caused by fluid aspiration into the vent port. J Thorac Cardiovasc Surg 128 4 (2004) 619-621
103. Chinn R., Dembitsky W., Eaton L., et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 51 (2005) 461-470
104. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129 (2005) 9-17
105. Koul B., Solem J.O., Steen S., et al. HeartMate left ventricular assist device as bridge to heart transplantation. Ann Thorac Surg 65 (1998) 1625-1630
106. Korfer R., El-Banayosy A., Arusoglu L., et al. Single-center experience with the thoratec ventricular assist device. J Thorac Cardiovasc Surg 119 (2000) 596-600
107. Frazier O.H., Rose E.A., Oz M.C., et al. HeartMate LVAS Investigators. Left Ventricular Assist System. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122 (2001) 1186-1195
108. Dang N.C., Topkara V.K., Kim B.T., et al. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. J Thorac Cardiovasc Surg 130 (2005) 1302-1309
109. Frazier O., Myers T., Palanichamy N., et al. Initial clinical experience with the Heartmate II left ventricular assist system. The Journal of Heart and Lung Transplantation 25 2 (2006) 149
110. Siegenthaler M.P., Frazier O.H., Beyersdorf F., et al. Mechanical reliability of the Jarvik 2000 Heart. Ann Thorac Surg 81 (2006) 1752-1758
111. Leprince P., Bonnet N., Rama A., et al. Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: a single-center 15-year experience. J Heart Lung Transplant 22 (2003) 1296-1303
112. Deng M.C., Loebe M., El-Banayosy A., et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 103 (2001) 231-237
113. Portner P.M., Jansen P.G., Oyer P.E., et al. Improved outcomes with an implantable left ventricular assist system: a multicenter study. Ann Thorac Surg 71 (2001) 205-209
114. Copeland J.G., Smith R.G., Arabia F.A., et al. CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 351 (2004) 859-867
115. El Banayosy A., Arusoglu L., Morshuis M., et al. CardioWest total artificial heart: Bad Oeynhausen experience. Ann Thorac Surg 80 (2005) 548-552